Barclays’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.73M | Sell |
|
|||||
|
2025
Q2 | $12.7M | Buy |
|
|||||
|
2025
Q1 | $10.3M | Buy |
|
|||||
|
2024
Q4 | $10.3M | Buy |
|
|||||
|
2024
Q3 | $7.74M | Buy |
|
|||||
|
2024
Q2 | $1.86M | Sell |
|
|||||
|
2024
Q1 | $4.91M | Sell |
|
|||||
|
2023
Q4 | $8.5M | Buy |
|
|||||
|
2023
Q3 | $3.54M | Buy |
|
|||||
|
2023
Q2 | $3.04M | Buy |
|
|||||
|
2023
Q1 | $2.24M | Sell |
|
|||||
|
2022
Q4 | $2.64M | Buy |
|
|||||
|
2022
Q3 | $1.28M | Buy |
|
|||||
|
2022
Q2 | $796K | Sell |
|
|||||
|
2022
Q1 | $1.21M | Sell |
|
|||||
|
2021
Q4 | $3.44M | Buy |
|
|||||
|
2021
Q3 | $1.87M | Buy |
|
|||||
|
2021
Q2 | $527K | Sell |
|
|||||
|
2021
Q1 | $1.59M | Buy |
|
|||||
|
2020
Q4 | $675K | Sell |
|
|||||
|
2020
Q3 | $631K | Sell |
|
|||||
|
2020
Q2 | $430K | Sell |
|
|||||
|
2020
Q1 | $2.01M | Buy |
|
|||||
|
2019
Q4 | $674K | Sell |
|
|||||
|
2019
Q3 | $871K | Sell |
|
|||||
|
2019
Q2 | $972K | Buy |
|
|||||
|
2019
Q1 | $359K | Sell |
|
|||||
|
2018
Q4 | $1.22M | Sell |
|
|||||
|
2018
Q3 | $3.72M | Buy |
|
|||||
|
2018
Q2 | $2.26M | Sell |
|
|||||
|
2018
Q1 | $1.64M | Buy |
|
|||||
|
2017
Q4 | $942K | Buy |
|
|||||
|
2017
Q3 | $22K | Sell |
|
|||||
|
2017
Q2 | $679K | Sell |
|
|||||
|
2017
Q1 | $934K | Sell |
|
|||||
|
2016
Q4 | $1.76M | Buy |
|
|||||
|
2016
Q3 | $970K | Buy |
|
|||||
|
2016
Q2 | $144K | Buy |
|